Humacyte, Inc. (NASDAQ:HUMA) Given Consensus Recommendation of “Buy” by Brokerages
Shares of Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) have been assigned an average rating of “Buy” from the eight ratings firms that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation, six have assigned a buy recommendation and one has assigned a strong buy recommendation to the […]
Shares of Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) have been assigned an average rating of “Buy” from the eight ratings firms that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation, six have assigned a buy recommendation and one has assigned a strong buy recommendation to the […]
